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Introduction
Ischemic heart disease (IHD) is the most common cause
of disability and death worldwide.1 With the increasing use
of new medical technologies such as percutaneous intra-
coronary intervention (PCI), off-pump coronary artery by-
pass surgery and laparoscopic surgery, the impact of IHD
on healthcare expenditures has substantially and simultane-
ously increased.2, 3 Thus, the prevention of IHD is a public
health priority. Cigarette smoking, hypertension, diabetes,
dyslipidemia, obesity and psychosocial factors are estab-
lished independent risk factors for IHD.4-11 Treatment for
hypertension,12, 13 diabetes14 and dyslipidemia15 has convinc-
ingly helped to decrease the risk of IHD. Because of the
strength of evidence supporting their role in the pathogene-
sis of IHD, the four major risk factors of cigarette smoking,
hypertension, diabetes and dyslipidemia have been labeled
as conventional risk factors. Although the importance of
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Aim Although the important role of conventional risk factors (cigarette smoking, hypertension, diabetes and dyslipidemia) in
the pathogenesis of ischemic heart disease (IHD) has been established, how frequently IHD is preceded by exposure to con-
ventional risk factors remains controversial. The present study aimed to identify the prevalence of hypertension, diabetes and
dyslipidemia among patients with IHD and examine associations between each of them with IHD in a Japanese population.
Methods Data were collected from health insurance claims in May 2010 for National Health Insurance beneficiaries aged 40-
79 years in Nagasaki Prefecture, Japan. One sex- and age-matched control was randomly selected for each of 42,236 patients
with IHD (International Classification of Diseases, 10th Revision code: I20-25). The prevalence of hypertension, diabetes and
dyslipidemia and the number of these risk factors were compared between the patients and controls. Associations between
risk factors and IHD were examined using a conditional logistic regression model.
Results Over 90% of patients with IHD had at least one of hypertension, diabetes or dyslipidemia. The odds of IHD were 4.5-
fold (95% confidence interval [CI]: 4.3, 4.7), 4.2-fold (95% CI: 3.9, 4.6) and 5.3-fold (95% CI: 4.9, 5.7) higher for patients with
hypertension, diabetes and dyslipidemia, respectively, compared with patients without any of these risk factors. Patients with
several risk factors were at increased risk for IHD.
Conclusion Comprehensive risk reduction strategies that encourage a healthy lifestyle and diet and promote the recognition,
evaluation and management of conventional risk factors are important to prevent IHD.
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these risk factors in the development of IHD is established,
some studies indicate that over 50% of patients with IHD
do not have them.16-18 Furthermore, the identification of
non-conventional risk factors such as novel molecular and
genetic biomarkers that might play a role in the development
of IHD has recently received considerable attention.19, 20 On
the other hand, recent epidemiological studies have chal-
lenged this assertion by demonstrating that most patients
with IHD in Western populations have at least one conven-
tional risk factor.21, 22
However, the prevalence of conventional risk factors
among patients with IHD in the Japanese population is poorly
described. A good understanding of the risk factors for IHD
is important to guide clinical medicine, public health poli-
cies and research efforts. We therefore conducted a case-
control study to identify the prevalence of hypertension,
diabetes and dyslipidemia among patients with IHD and ex-
amined associations between these risk factors and IHD in
a representative Japanese population.
Methods
The Japanese health system provides universal coverage
for the general population through a health insurance sys-
tem for employees and their families (60% of the popula-
tion) and through a National Health Insurance (NHI) sys-
tem for the self-employed, retired and unemployed (40% of
the population). Hospitals and clinics submit monthly claims
to the insurers that include the diagnoses and costs for di-
rect reimbursement after patients have been treated.
Data were collected from health insurance claims in May
2010 for NHI beneficiaries aged 40-79 years in Nagasaki
Prefecture, Japan. Among 391,485 beneficiaries (women:
211,495, 54.0%), 258,293 (66.0%; women: 146,309, 56.6%)
were identified from health insurance claims as having re-
ceived medical care during May 2010.
Diseases were coded following the International Classification
of Diseases, 10th Revision (ICD-10). Overall, 42,236 pa-
tients were defined as having IHD (ICD 10 code: I20-25).
Among the remaining 216,057 patients, those with a diag-
nosis of cardiovascular disease (ICD-10 code: I60-69), ar-
teries, arterioles and capillaries diseases(ICD-10 code:I70-
79), liver disease (ICD-10 code: K70-77) or kidney failure
(ICD-10 code: N17-19) were excluded, leaving 155,726 pa-
tients (women: 92,731, 59.5%). One sex- and age-matched
(within 5-year age groups) control patient was randomly se-
lected for each patient with IHD. The prevalence of hyper-
tension, diabetes and dyslipidemia was compared between
patients with IHD and controls. Hypertension was defined
as a record of ICD-10 code I10-13. Diabetes was defined as
a record of ICD-10 code E11-14, and dyslipidemia was de-
fined as a record of ICD-10 code E78.
Data were analyzed using SAS software version 9.1.3
(SAS Institute, Cary, NC, USA). The prevalence of hyper-
tension, diabetes and dyslipidemia and the number of risk
factors were compared between patients with IHD and con-
trols. Differences in categorical variables between patients
with IHD and controls were examined using the chi-square
test. The strength of the association between hypertension,
diabetes and dyslipidemia and IHD was estimated using a
conditional logistic regression model (SAS PHREG proce-
dure) and is expressed as odds ratios (ORs) and 95% confi-
dence intervals (CIs). Associations between combinations
or numbers of conventional risk factors and IHD were also
estimated.
Results
Figure 1 shows the number of medical care claims sub-
mitted due to IHD per 100 beneficiaries by sex and age.
The average numbers of IHD per 100 beneficiaries were
10.6 and 11.1 for women and men, respectively. More men
than women had IHD in every age group. The number of
patients with IHD per 100 beneficiaries increased from 0.7
to 22.1 for men and from 0.9 to 20.7 for women for age
groups 40-44 years to 75-79 years, respectively.
Figure 2 shows that the proportions of patients with IHD
accompanied by one, two and all three conventional risk
factors were 31.1%, 38.3% and 22.3%, respectively; only
8.3% of patients had no apparent risk factors. The prevalence
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Figure 1. Number of medical cares for ischemic heart disease per
100 beneficiaries according to sex and age, Nagasaki Prefecture,
Japan, 2010 (n = 391,485).
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of hypertension, diabetes and dyslipidemia among patients
with IHD was 76.6% (78.2% in men and 75.2% in women),
43.0% (50.0% in men and 36.8% in women) and 54.9%
(49.5% in men and 59.7% in women), respectively.
Table 1 shows the baseline characteristics of the patients
with IHD and controls. Over 90% of the patients with IHD
were over 60 years of age and more of them were women
(52.9% vs. 47.1%, P < 0.001). Patients with IHD had a sig-
nificantly higher overall prevalence of hypertension (76.6%
vs. 47.5%, P < 0.001), diabetes (43.0% vs. 19.9%, P < 0.001)
and dyslipidemia (54.9% vs. 27.5%, P < 0.001) than controls.
The proportion of individuals without any of these conven-
tional risk factors was significantly higher among controls
than patients with IHD (39.5% vs. 8.3%, P < 0.001).
Table 2 shows the prevalence of conventional risk factors
among patients with IHD and controls according to sex and
age. The prevalence of all three conventional risk factors in
each sex and age group was significantly higher among pa-
tients with IHD than controls (P < 0.01). The proportion of
individuals without any of the three conventional risk factors
decreased significantly with increasing age (P < 0.01 for trend).
Table 3 shows the results of conditional logistic regres-
sion analysis. The ORs were 4.5 (95% CI: 4.3, 4.7), 4.2
(95% CI: 3.9, 4.6) and 5.3 (95% CI: 4.9, 5.7) for patients
with hypertension, diabetes and dyslipidemia, respectively,
compared with those without any of these risk factors. The
OR was higher for dyslipidemia than those for hypertension
and diabetes. Any combination of these conventional risk
factors was associated with a higher risk of IHD. Notably,
the OR was 16.4 (95% CI: 15.4, 17.5) among patients with
all three risk factors. The association between risk factors
and IHD analyzed based on numbers of risk factors was
close and graded (Figure 3).
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Figure 2. Prevalence of hypertension, diabetes and dyslipidemia
among patients with ischemic heart disease, Nagasaki Prefecture,
Japan, 2010 (n = 42,236).
Figure 3. Risk of ischemic heart disease according to numbers of


















































Table 1. Baseline characteristics of the patients.
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Discussion
Our study used claims-based diagnoses to investigate re-
lationships between IHD and hypertension, diabetes and
dyslipidemia among a Japanese population. We found that
over 90% and over 50% of patients with IHD had at least
one and at least two conventional risk factors, respectively.
All three of the conventional risk factors were significantly
associated with IHD and individuals with multiple risk fac-
tors were at increased risk for IHD.
The prevalence of conventional risk factors for IHD in
Western populations has been reported. Khot et al.21 ana-
lyzed data from 14 randomized clinical trials (n = 122,458)
and found that 80-90% of patients who developed clinically
significant IHD had at least one conventional risk factor.
Greenland et al.22 studied three large long-term prospective
US cohorts (n = 386,915), and found that 87-100% of pa-
tients who experienced a fatal IHD event had at least one
conventional risk factor. Our findings indicated that over
90% of Japanese patients with IHD have at least one of hy-
pertension, diabetes or dyslipidemia, which is similar to the
findings from non-Japanese populations.
The prevalence of conventional risk factors was higher
in the present, than in other published studies. Nieto et
al.23 demonstrated that 84% and 42% of hypertensive and
16
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Table 2. Prevalence of conventional risk factors among patients with IHD and controls according to sex and age.
Data are expressed as ratios (%). Prevalence differences between patients with IHD and controls are statistically significant at P < 0.01 unless otherwise noted.
*P <0.01 for trend with increasing age in patients with IHD and controls.

















Table 3. Odds ratios (ORs) and 95% confidence intervals (95%
CIs) for ischemic heart disease.
Hairong Huang et al.: Hypertension, diabetes and dyslipidemia and ischemic heart disease
hypercholesterolemic individuals, respectively, aged 45 to
64 years in the United States were aware of their condi-
tions. Franse et al.24 demonstrated a respective 15.6% and
8.0% prevalence of diagnosed and undiagnosed diabetes in an
older population in the United States. Most previous studies
analyzed data from community dwelling populations, whereas
the present study included only data from individuals who
had used medical services and used claim-based diagnoses
to identify conventional risk factors, which provides proven
accurate and dependable information about diseases.25-27
These differences might explain the higher prevalence of
conventional risk factors identified in the present study.
Consensus regarding the role of conventional risk factors
in the development of IHD worldwide is growing. Yusuf
and colleagues4 showed that dyslipidemia, smoking, hyper-
tension, diabetes and psychosocial factors were the most
important risk factors for acute myocardial infarction in a
case-control study of 52 countries that represented every in-
habited continent. Stamler et al.28 indicated that individuals
without any conventional risk factors had an 80-90% lower
risk of coronary heart disease mortality compared with the
rest of the population in five US cohorts. Furthermore, non-
smokers with low blood pressure and a low cholesterol level
in Göteborg had an age-adjusted relative risk of 0.09 com-
pared with the average population of that city.29 Wald and
Law30 suggested that a combination of statins, antihypertensive
drugs, folic acid and aspirin could potentially reduce IHD
events by over 80%. In addition, lifestyle modification to
prevent the development of conventional risk factors, in-
cluding increased consumption of fruits and vegetables,
moderate activity and avoidance of smoking, also appears
to reduce the risk of IHD.31-33 Our findings that hyperten-
sion, diabetes and dyslipidemia were significantly associ-
ated with IHD and that having multiple risk factors in-
creased the risk for IHD reinforce the important role of
conventional risk factors in the development of IHD.
Studies of novel molecular and genetic biomarkers, such as
C-reactive protein, fibrinogen, lipoprotein and homocysteine,
might provide insight into the pathogenesis of IHD and into
the monitoring and treatment of patients.19 They may also
play a role in risk assessment in specific clinical situations.20
However, their optimal application to routine screening and
risk stratification remains to be determined, and they are
unlikely to have major public health importance.19, 20 Based
on the high prevalence of conventional risk factors among
patients with IHD and their role in the development of
IHD, we suggest that clinical medicine, public health poli-
cies and research efforts should place more emphasis on
conventional risk factors. An aggressive prevention strategy
including lifestyle modification to prevent the development
of conventional risk factors and early medical intervention
to treat hypertension, diabetes and dyslipidemia would con-
tribute to reducing IHD.
The strengths of our study include a large sample popu-
lation of over 40,000 patients with IHD and controls from
the same region and claims-based diagnoses of risk factors.
These factors improved the accuracy of risk factor estima-
tion and the applicability of our findings to the general
population. Policy makers and physicians can better under-
stand the impact of preventing or modifying these risk fac-
tors on the risk of future IHD based on the present findings.
However, some limitations must be considered in the in-
terpretation of our findings. Firstly, we assessed conven-
tional risk factors at the time of IHD diagnosis, not years in
advance. Secondly, information about some important risk
factors such as cigarette smoking, obesity and psychosocial
factors was unavailable. Thirdly, since conditions were di-
agnosed only from health insurance claims during a period
of one month, information about patients who did not visit
medical facilities has been missed. These patients might tend
to have clinically mild to moderate IHD. Diagnostic criteria
for diseases might vary among different doctors. These fac-
tors might have caused sampling bias in this study. In addi-
tion, information about the severity and treatment of IHD
and its associated conventional risk factors was also un-
available from health insurance claims. Further studies to
assess the effect of medical treatment of conventional risk
factors on risk of IHD would be helpful to improve the ef-
fectiveness of IHD reduction strategies.
In conclusion, our findings show that over 90% of a
Japanese population with IHD had at least one of hyperten-
sion, diabetes or dyslipidemia and that all of these risk fac-
tors were significantly associated with IHD. Comprehensive
risk reduction strategies that encourage a healthy lifestyle
and dieting, and promote the recognition, evaluation and
management of conventional risk factors are important to
prevent IHD.
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